GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B7I2R7)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B7I2R7) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B7I2R7
Type
protein
Length
417 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x0C2662d9b03a8d2eD95cE616E19f3B0412E0928E
Molecule
Serine hydroxymethyltransferase
UniProt
B7I2R7
Pockets
3 · best druggability 0.44

Structure

1 distinct chain · 48% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41748% helix, 13% strandB7I2R7

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11580.440.7631empty
21460.410.7419empty
3560.270.7415empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.